skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 34  for All Library Resources

Results 1 2 next page
Refined by: resource type: Standards remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
Material Type:
Standards
Add to My Research

Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

2
Ponesimod for treating relapsing–remitting multiple sclerosis
Material Type:
Standards
Add to My Research

Ponesimod for treating relapsing–remitting multiple sclerosis

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

3
Givosiran for treating acute hepatic porphyria
Material Type:
Standards
Add to My Research

Givosiran for treating acute hepatic porphyria

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

4
Romosozumab for treating severe osteoporosis
Material Type:
Standards
Add to My Research

Romosozumab for treating severe osteoporosis

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

5
Ovarian cancer: identifying and managing familial and genetic risk
Material Type:
Standards
Add to My Research

Ovarian cancer: identifying and managing familial and genetic risk

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

6
Fetal alcohol spectrum disorder
Material Type:
Standards
Add to My Research

Fetal alcohol spectrum disorder

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

7
Caesarean birth
Material Type:
Standards
Add to My Research

Caesarean birth

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

8
Abortion care
Material Type:
Standards
Add to My Research

Abortion care

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

9
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer
Material Type:
Standards
Add to My Research

Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

10
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
Material Type:
Standards
Add to My Research

Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

11
Abortion care
Material Type:
Standards
Add to My Research

Abortion care

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

12
Antenatal care
Material Type:
Standards
Add to My Research

Antenatal care

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

13
Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
Material Type:
Standards
Add to My Research

Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

14
Intrapartum care: existing medical conditions and obstetric complications
Material Type:
Standards
Add to My Research

Intrapartum care: existing medical conditions and obstetric complications

NICE Guidance, 2020

Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

15
Heart valve disease presenting in adults: investigation and management
Material Type:
Standards
Add to My Research

Heart valve disease presenting in adults: investigation and management

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

16
Postnatal care
Material Type:
Standards
Add to My Research

Postnatal care

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

17
Pelvic floor dysfunction: prevention and non-surgical management
Material Type:
Standards
Add to My Research

Pelvic floor dysfunction: prevention and non-surgical management

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

18
Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab
Material Type:
Standards
Add to My Research

Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

19
Intrapartum care for women with existing medical conditions or obstetric complications and their babies
Material Type:
Standards
Add to My Research

Intrapartum care for women with existing medical conditions or obstetric complications and their babies

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

20
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Material Type:
Standards
Add to My Research

Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer

NICE Guidance, 2019

Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

Results 1 - 20 of 34  for All Library Resources

Results 1 2 next page

Searching Remote Databases, Please Wait